form10q.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2011
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT
For the transition period from ________ to ___________.
Commission file number: 1-16053
_________________
MEDIA SCIENCES INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
87-0475073
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
8 Allerman Road, Oakland, NJ 07436
(Address of principal executive offices) (Zip Code)
(201) 677-9311
(Registrant’s telephone number, including area code)
_________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes o No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorted period that the registrant was required to submit and post such files). o Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):
|
Large accelerated filer o
|
Accelerated filer o
|
|
Non-accelerated filer o (Do not check if a smaller reporting company)
|
Smaller reporting company x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes x No
As of May 4, 2011, we had 13,492,374 shares of common stock outstanding.
AND SUBSIDIARIES
FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2011
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
ITEM 1.
|
|
3
|
|
|
|
|
|
3
|
|
|
|
|
|
4
|
|
|
|
|
|
5
|
|
|
|
|
|
6
|
|
|
|
|
|
7
|
|
|
|
ITEM 2.
|
|
20
|
|
|
|
ITEM 3.
|
|
24
|
|
|
|
ITEM 4.
|
|
24
|
PART II. OTHER INFORMATION
ITEM 1.
|
|
25
|
|
|
|
ITEM 1A.
|
|
25
|
|
|
|
ITEM 2.
|
|
25
|
|
|
|
ITEM 3.
|
|
25
|
|
|
|
ITEM 4.
|
|
25
|
|
|
|
ITEM 5.
|
|
25
|
|
|
|
ITEM 6.
|
|
25
|
|
|
|
|
|
26
|
PART I. FINANCIAL INFORMATION
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
March 31, 2011
|
|
June 30,
|
|
ASSETS
|
|
(Unaudited)
|
|
2010
|
|
CURRENT ASSETS:
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
6,628,346 |
|
|
$ |
317,611 |
|
Accounts receivable, net
|
|
|
1,397,343 |
|
|
|
2,674,918 |
|
Inventories, net
|
|
|
759,336 |
|
|
|
1,420,806 |
|
Taxes receivable
|
|
|
– |
|
|
|
50,506 |
|
Prepaid expenses and other current assets
|
|
|
67,587 |
|
|
|
205,423 |
|
Assets of discontinued operations
|
|
|
– |
|
|
|
7,281,721 |
|
Total Current Assets
|
|
|
8,852,612 |
|
|
|
11,950,985 |
|
|
|
|
|
|
|
|
|
|
PROPERTY AND EQUIPMENT, NET
|
|
|
925,106 |
|
|
|
1,129,222 |
|
|
|
|
|
|
|
|
|
|
OTHER ASSETS:
|
|
|
|
|
|
|
|
|
Goodwill and other intangible assets, net
|
|
|
1,120,072 |
|
|
|
1,120,072 |
|
Restricted cash held in escrow account
|
|
|
1,100,136 |
|
|
|
– |
|
Other assets
|
|
|
70,911 |
|
|
|
85,984 |
|
Total Other Assets
|
|
|
2,291,119 |
|
|
|
1,206,056 |
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
$ |
12,068,837 |
|
|
$ |
14,286,263 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
307,324 |
|
|
$ |
1,201,154 |
|
Accrued compensation and benefits
|
|
|
76,800 |
|
|
|
555,136 |
|
Accrued severance expense
|
|
|
502,610 |
|
|
|
– |
|
Other accrued expenses and current liabilities
|
|
|
564,686 |
|
|
|
443,641 |
|
Income tax payable
|
|
|
5,474 |
|
|
|
– |
|
Accrued product warranty costs
|
|
|
205,602 |
|
|
|
432,548 |
|
Deferred rent liability
|
|
|
34,853 |
|
|
|
28,493 |
|
10% subordinated debt, net of discount of $113,524 at March 31, 2011
|
|
|
1,136,476 |
|
|
|
– |
|
Deferred revenue
|
|
|
– |
|
|
|
20,097 |
|
Total Current Liabilities
|
|
|
2,833,825 |
|
|
|
2,681,069 |
|
|
|
|
|
|
|
|
|
|
OTHER LIABILITIES:
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
– |
|
|
|
2,340,863 |
|
Deferred rent liability
|
|
|
– |
|
|
|
29,517 |
|
10% subordinated debt, net of discount of $255,376 in June
|
|
|
– |
|
|
|
994,624 |
|
Deferred tax liabilities
|
|
|
– |
|
|
|
904,922 |
|
Total Other Liabilities
|
|
|
– |
|
|
|
4,269,926 |
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES
|
|
|
2,833,825 |
|
|
|
6,950,995 |
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY:
|
|
|
|
|
|
|
|
|
Preferred Stock, $.001 par value
|
|
|
|
|
|
|
|
|
Authorized 5,000,000 shares; none issued
|
|
|
– |
|
|
|
– |
|
Common Stock, $.001 par value 25,000,000 shares authorized;
|
|
|
|
|
|
|
|
|
issued and outstanding, respectively, 13,492,374 and 13,342,374 shares at
March 31, 2011 and 13,292,374 and 12,699,914 shares at June 30, 2010
|
|
|
13,342 |
|
|
|
12,700 |
|
Additional paid-in capital
|
|
|
13,631,183 |
|
|
|
13,277,405 |
|
Accumulated other comprehensive income (loss)
|
|
|
23,854 |
|
|
|
1,402 |
|
Accumulated deficit
|
|
|
(4,433,367 |
) |
|
|
(5,956,239 |
) |
Total Shareholders’ Equity
|
|
|
9,235,012 |
|
|
|
7,335,268 |
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
$ |
12,068,837 |
|
|
$ |
14,286,263 |
|
See accompanying notes to condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
|
|
Three Months Ended
March 31,
|
|
|
Nine Months Ended
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
NET REVENUES
|
|
$ |
2,227,666 |
|
|
$ |
2,141,376 |
|
|
$ |
7,072,304 |
|
|
$ |
6,668,914 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF GOODS SOLD:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold, excluding depreciation and
amortization, product warranty, shipping and freight
|
|
|
985,347 |
|
|
|
805,113 |
|
|
|
2,938,402 |
|
|
|
2,031,264 |
|
Depreciation and amortization
|
|
|
52,576 |
|
|
|
54,755 |
|
|
|
165,453 |
|
|
|
214,296 |
|
Product warranty
|
|
|
37,578 |
|
|
|
468,261 |
|
|
|
447,529 |
|
|
|
1,456,124 |
|
Shipping and freight
|
|
|
16,758 |
|
|
|
146,992 |
|
|
|
223,845 |
|
|
|
414,244 |
|
Total cost of goods sold
|
|
|
1,092,259 |
|
|
|
1,475,121 |
|
|
|
3,775,229 |
|
|
|
4,115,928 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GROSS PROFIT
|
|
|
1,135,407 |
|
|
|
666,255 |
|
|
|
3,297,075 |
|
|
|
2,552,986 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER COSTS AND EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
65,625 |
|
|
|
264,787 |
|
|
|
335,800 |
|
|
|
755,071 |
|
Selling, general and administrative, excluding
depreciation and amortization and severance
|
|
|
938,165 |
|
|
|
1,920,799 |
|
|
|
3,687,723 |
|
|
|
5,240,228 |
|
Severance
|
|
|
– |
|
|
|
– |
|
|
|
1,682,427 |
|
|
|
– |
|
Depreciation and amortization
|
|
|
28,613 |
|
|
|
45,432 |
|
|
|
105,804 |
|
|
|
183,230 |
|
Total other costs and expenses
|
|
|
1,032,403 |
|
|
|
2,231,018 |
|
|
|
5,811,754 |
|
|
|
6,178,529 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME (LOSS) FROM OPERATIONS
|
|
|
103,004 |
|
|
|
(1,564,763 |
) |
|
|
(2,514,679 |
) |
|
|
(3,625,543 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
|
|
|
– |
|
|
|
213,769 |
|
|
|
– |
|
|
|
213,769 |
|
Interest expense
|
|
|
(31,250 |
) |
|
|
(89,347 |
) |
|
|
(166,474 |
) |
|
|
(266,116 |
) |
Interest income
|
|
|
7,610 |
|
|
|
46 |
|
|
|
10,297 |
|
|
|
117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on change in fair value of warrant liabilities
|
|
|
– |
|
|
|
4,924 |
|
|
|
– |
|
|
|
(38 |
) |
Amortization of debt discount on convertible debt
|
|
|
(50,800 |
) |
|
|
(37,856 |
) |
|
|
(141,853 |
) |
|
|
(105,708 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
|
|
28,564 |
|
|
|
(1,473,227 |
) |
|
|
(2,812,709 |
) |
|
|
(3,783,519 |
) |
Benefit (Provision) for income taxes
|
|
|
(4,000 |
) |
|
|
(2,033,167 |
) |
|
|
1,299,260 |
|
|
|
(1,934,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS) FROM CONTINUING OPERATIONS
|
|
|
24,564 |
|
|
|
(3,506,394 |
) |
|
|
(1,513,449 |
) |
|
|
(5,718,098 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF INCOME TAXES
|
|
|
(7,584 |
) |
|
|
803,383 |
|
|
|
166,881 |
|
|
|
2,705,002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAIN ON SALE OF DISCONTINUED OPERATIONS, NET OF INCOME TAXES
|
|
|
– |
|
|
|
– |
|
|
|
2,869,440 |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
|
$ |
16,980 |
|
|
$ |
(2,703,011 |
) |
|
$ |
1,522,872 |
|
|
$ |
(3,013,096 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC EARNINGS (LOSS) PER SHARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$ |
0.00 |
|
|
$ |
(0.29 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.48 |
) |
Discontinued operations
|
|
$ |
0.00 |
|
|
$ |
0.07 |
|
|
$ |
0.24 |
|
|
$ |
0.23 |
|
Net income (loss)
|
|
$ |
0.00 |
|
|
$ |
(0.22 |
) |
|
$ |
0.12 |
|
|
$ |
(0.25 |
) |
DILUTED EARNINGS (LOSS) PER SHARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$ |
0.00 |
|
|
$ |
(0.29 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.48 |
) |
Discontinued operations
|
|
$ |
0.00 |
|
|
$ |
0.07 |
|
|
$ |
0.24 |
|
|
$ |
0.23 |
|
Net income (loss)
|
|
$ |
0.00 |
|
|
$ |
(0.22 |
) |
|
$ |
0.12 |
|
|
$ |
(0.25 |
) |
WEIGHTED AVERAGE SHARES USED TO COMPUTE LOSS PER SHARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
13,354,088 |
|
|
|
12,291,692 |
|
|
|
12,845,972 |
|
|
|
12,025,210 |
|
Diluted
|
|
|
13,426,525 |
|
|
|
12,291,692 |
|
|
|
12,845,972 |
|
|
|
12,025,210 |
|
See accompanying notes to condensed consolidated financial statements
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY AND
COMPREHENSIVE INCOME
NINE MONTHS ENDED MARCH 31, 2011
(UNAUDITED)
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Other
|
|
|
|
|
|
Total
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
Comprehensive
|
|
|
Accumulated
|
|
|
Shareholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Income (loss)
|
|
|
Deficit
|
|
|
Equity
|
|
BALANCES, JUNE 30, 2010
|
|
|
12,699,914 |
|
|
$ |
12,700 |
|
|
$ |
13,277,405 |
|
|
$ |
1,402 |
|
|
$ |
(5,956,239 |
) |
|
$ |
7,335,268 |
|
Components of comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
1,522,872 |
|
|
|
1,522,872 |
|
Cumulative translation adjustment
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
22,452 |
|
|
|
– |
|
|
|
22,452 |
|
Total comprehensive income
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
1,545,324 |
|
Vested restricted stock units
|
|
|
642,460 |
|
|
|
642 |
|
|
|
(642 |
) |
|
|
– |
|
|
|
– |
|
|
|
– |
|
Stock-based compensation expense
|
|
|
– |
|
|
|
– |
|
|
|
354,420 |
|
|
|
– |
|
|
|
– |
|
|
|
354,420 |
|
BALANCES, MARCH 31, 2011
|
|
|
13,342,374 |
|
|
$ |
13,342 |
|
|
$ |
13,631,183 |
|
|
$ |
23,854 |
|
|
$ |
(4,433,367 |
) |
|
$ |
9,235,012 |
|
See accompanying notes to condensed consolidated financial statements.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
|
|
Nine Months Ended
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
1,522,872 |
|
|
$ |
(3,013,096 |
) |
Adjustments to reconcile net loss to net cash used in operating
|
|
|
|
|
|
|
|
|
activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
332,239 |
|
|
|
545,321 |
|
Stock-based compensation expense
|
|
|
353,013 |
|
|
|
470,679 |
|
Deferred income taxes
|
|
|
(1,149,630 |
) |
|
|
1,934,579 |
|
Provision for (reduction of) inventory obsolescence reserves
|
|
|
37,707 |
|
|
|
(20,053 |
) |
Provision for (recoveries of) returns and doubtful accounts allowance
|
|
|
(32,486 |
) |
|
|
109,239 |
|
Amortization of debt discount on convertible debt
|
|
|
141,853 |
|
|
|
105,708 |
|
Loss on change in fair value of warrant liabilities
|
|
|
– |
|
|
|
38 |
|
Gain on sale of toner business
|
|
|
(2,869,440 |
) |
|
|
– |
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
1,309,936 |
|
|
|
207,602 |
|
Inventories
|
|
|
179,244 |
|
|
|
(429,411 |
) |
Income taxes
|
|
|
55,980 |
|
|
|
(29,086 |
) |
Prepaid expenses and other current assets
|
|
|
61,579 |
|
|
|
165,886 |
|
Accounts payable
|
|
|
(893,734 |
) |
|
|
293,197 |
|
Accrued compensation and benefits
|
|
|
(478,336 |
) |
|
|
(131,042 |
) |
Accrued severance
|
|
|
502,610 |
|
|
|
– |
|
Other accrued expenses and current liabilities
|
|
|
144,729 |
|
|
|
(562,170 |
) |
Accrued product warranty costs
|
|
|
(226,946 |
) |
|
|
(611 |
) |
Deferred rent liability
|
|
|
(23,157 |
) |
|
|
(56,448 |
) |
Deferred revenue
|
|
|
(20,097 |
) |
|
|
(205,835 |
) |
Net cash used in operating activities
|
|
|
(1,052,064 |
) |
|
|
(615,503 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Increase in restricted cash
|
|
|
(1,100,136 |
) |
|
|
– |
|
Purchases of property and equipment
|
|
|
(237,498 |
) |
|
|
(148,461 |
) |
Proceeds from sale of operating toner business
|
|
|
11,042,500 |
|
|
|
– |
|
Net cash provided (used) in investing activities
|
|
|
9,704,866 |
|
|
|
(148,461 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Decrease in restricted cash
|
|
|
– |
|
|
|
32,515 |
|
Bank credit line proceeds (repayments), net
|
|
|
(840,863 |
) |
|
|
439,057 |
|
Bank term loan repayments
|
|
|
(1,500,000 |
) |
|
|
– |
|
Capital lease obligation repayments
|
|
|
– |
|
|
|
(69,815 |
) |
Net cash used in financing activities
|
|
|
(2,340,863 |
) |
|
|
401,757 |
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
(1,204 |
) |
|
|
(30,651 |
) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
|
|
6,310,735 |
|
|
|
(392,858 |
) |
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
|
|
317,611 |
|
|
|
550,602 |
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
|
$ |
6,628,346 |
|
|
$ |
157,744 |
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$ |
83,680 |
|
|
$ |
221,369 |
|
Income taxes paid (refunded)
|
|
$ |
(44,500 |
) |
|
$ |
49,160 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION
Nature of Business. Media Sciences International, Inc. is a holding company which conducts its business through its operating subsidiaries. The Company is a manufacturer of business color printer supplies and industrial ink applications, which the Company distributes through a distribution channel and direct to original equipment manufacturers. As more fully discussed in Note 9, the Company sold substantially all of its assets related to its toner business and discontinued distributing toner related products. The resulting business is a manufacturer of solid ink and industrial ink products sold to an individual company or through an exclusive distribution channel. On April 22, 2011, the Company entered into an agreement settling a patent infringement lawsuit. Under the terms of the settlement, the parties resolved, on mutually agreeable terms, infringement claims on certain Xerox-held patents related to the shape of the ink sticks, and the parties will exchange certain other business and financial considerations, over a brief ensuing period. The Company will deliver to Xerox certain inventory and assets related to industrial ink, the Company will assign certain patent and other intellectual property rights to Xerox, and the Company will cease manufacturing its inks for use in Xerox color printers. The Company will continue to manufacture certain industrial ink products and to supply those products to Xerox for several months, after which the Company will cease manufacturing industrial ink products (see Note 11).
Basis of Presentation. The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to Article 8 of Rule S-X. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal, recurring adjustments) necessary for a fair presentation of the financial position, results of operations and cash flows for the periods indicated. You should read these condensed consolidated financial statements in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2010, filed with the SEC on September 28, 2010. The June 30, 2010 consolidated balance sheet data was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America.
The consolidated financial statements include the accounts of Media Sciences International, Inc., a Delaware corporation, and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. During the quarter ended December 31, 2010, the Company discontinued selling toner related products as more fully described in Note 9. Accordingly, the financial statements for the periods prior to the sale have been adjusted to reflect the discontinued operations of the toner business and the related continuing operations of the Company. As of March 31, 2011, there have been no significant changes to any of the Company’s accounting policies as set forth in the Annual Report on Form 10-K for the year ended June 30, 2010.
The results of operations for the three months and nine months ended March 31, 2011 are not necessarily indicative of the results that may be expected for any other interim period or for the full year ending June 30, 2011.
Accumulated Other Comprehensive Income (Loss). Accumulated other comprehensive income (loss) represents currency translation adjustments. Assets and liabilities of the Company’s United Kingdom and China subsidiaries have been translated at current exchange rates, and related revenues and expenses have been translated at average rates of exchange in effect during the period. The functional currency of the Company’s foreign subsidiaries is as follows: Media Sciences UK, Ltd., the British pound; Media Sciences Hong Kong Co. Limited, the Hong Kong dollar; and Media Sciences (Dongguan) Company Limited, the Chinese yuan. Realized foreign currency transaction gains and losses are recorded as a component of selling, general and administrative expense.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION (CONTINUED)
Estimates and Uncertainties. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s most significant estimates and assumptions made in the preparation of the financial statements relate to revenue recognition, accounts receivable reserves, inventory reserves, income taxes, income tax valuation allowance, warranty reserves, and certain accrued expenses. Actual results could differ from those estimates.
Fair Value Measurements. The Company measures fair value in accordance with authoritative guidance for fair value measurements, which defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. The authoritative guidance defines fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
·
|
Level 1 – unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.
|
·
|
Level 2 – inputs other than quoted prices included within Level 1 that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.
|
·
|
Level 3 – unobservable inputs for the asset or liability only used when there is little, if any, market activity for the asset or liability at the measurement date.
|
This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.
Fair Value of Financial Instruments. The carrying value of cash and cash equivalents, accounts receivable, accounts payable and short-term debt reasonably approximate their fair value due to the relatively short maturities of these instruments. Long-term debt carrying values approximate their fair values at the balance sheet dates. The fair value estimates presented herein were based on market or other information available to management. The use of different assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts.
Restricted Cash. At March 31, 2011 and June 30, 2010, $1,100,136, and $87,843, respectively, of bank deposits were classified as restricted. The June 30, 2010 balance was restricted due to regulatory restrictions impacting the availability of the funds during dissolution of the legal entity in China. This restricted cash is reflected in prepaid expenses and other current assets in the condensed consolidated balance sheet of June 30, 2010. The March 31, 2011 balance was restricted due to funds held in escrow in conjunction with an indemnity clause related to the sale of toner assets (see also Note 9). This restricted cash is reflected in other assets in the condensed consolidated balance sheet at March 31, 2011.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION (CONTINUED)
Income Taxes. The Company recognizes deferred tax assets, net of applicable valuation allowances, related to net operating loss carry-forwards and certain temporary differences and deferred tax liabilities related to certain temporary differences. The Company recognizes a future tax benefit to the extent that realization of such benefit is considered to be more likely than not. The Company has incurred substantial losses before income taxes for several years before and for the year ended June 30, 2010. Accordingly, the Company provided a valuation allowance as of March 31, 2010 for all of its then remaining deferred tax assets as it was deemed more likely than not that certain federal net operating loss carry forwards and other future deductible temporary differences included in the Company’s deferred tax assets would not be realized. This also resulted in the Company restoring its deferred tax liability for indefinite-lived intangibles at that time. As a result of the sale of the toner business which included certain indefinite-lived intangibles the Company reduced its deferred tax liability to zero at December 31, 2010. Additionally, as a result of the gain on the sale of the toner business, the Company reduced certain of its valuation allowances resulting in a tax benefit from continuing operations and an offsetting tax provision recorded against the gain on discontinued operations.
NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS
Fair Value Accounting
In January 2010, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance for fair value measurements. This guidance now requires a reporting entity to disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and also to describe the reasons for these transfers. This authoritative guidance also requires enhanced disclosure of activity in Level 3 fair value measurements. The guidance for Level 3 fair value measurements disclosures becomes effective for the Company’s interim reporting period ending September 30, 2011 and the Company does not expect that this guidance will have an impact on its financial position, results of operations or cash flows as it is disclosure-only in nature.
Other Accounting Changes
In April 2010, the FASB issued ASU No. 2010-13, Compensation-Stock Compensation (Topic 718). This ASU provides amendments to Topic 718 to clarify that an employee share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity’s equity securities trades should not be considered to contain a condition that is not a market, performance, or service condition. Therefore, an entity would not classify such an award as a liability if it otherwise qualifies as equity. This standard becomes effective for the Company’s fiscal year, and interim periods on or after July 1, 2011. The Company does not expect this guidance to have an impact on our financial position, results of operations and cash flows.
In December 2010, the FASB issued Update No. 2010-28, Intangibles-Goodwill and Other (Topic 350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts (a consensus of the FASB Emerging Issues Task Force). This Update provides amendments to Topic 350 to clarify the guidance on how to determine the carrying amount or measure the fair value of the reporting unit when the reporting unit has zero or negative carrying amounts of goodwill. This standard becomes effective for the Company’s fiscal year, and interim periods on or after July 1, 2011. The Company does not expect this guidance to have an impact on our financial position, results of operations and cash flows.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 3 – CONDENSED CONSOLIDATED BALANCE SHEET COMPONENTS
|
|
|
March 31
2011
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
June 30, 2010
|
|
Accounts receivable, net
|
|
|
|
|
|
|
|
Accounts receivable, gross
|
|
|
$ |
1,553,537 |
|
|
$ |
2,863,598 |
|
Allowance for doubtful accounts
|
|
|
|
(40,000 |
) |
|
|
(20,000 |
) |
Allowance for returns
|
|
|
|
(116,194 |
) |
|
|
(168,680 |
) |
|
|
|
$ |
1,397,343 |
|
|
$ |
2,674,918 |
|
|
|
|
|
|
|
|
|
|
|
Inventories, net of reserves
|
|
|
|
|
|
|
|
|
|
Raw materials
|
|
|
$ |
435,112 |
|
|
$ |
555,252 |
|
Finished goods
|
|
|
|
477,458 |
|
|
|
981,081 |
|
Less: reserves for obsolescence
|
|
|
|
(153,234 |
) |
|
|
(115,527 |
) |
|
|
|
$ |
759,336 |
|
|
$ |
1,420,806 |
|
|
|
|
|
|
|
|
|
|
|
Property and Equipment, net
|
Useful Lives
|
|
|
|
|
|
|
|
|
Equipment
|
3 – 7 years
|
|
$ |
2,806,006 |
|
|
$ |
2,771,362 |
|
Furniture and fixtures
|
7 years
|
|
|
576,467 |
|
|
|
576,467 |
|
Automobiles
|
5 years
|
|
|
30,434 |
|
|
|
30,434 |
|
Leasehold improvements
|
5 – 10 years
|
|
|
929,762 |
|
|
|
913,743 |
|
Tooling and molds
|
3 years
|
|
|
692,231 |
|
|
|
675,618 |
|
|
|
|
|
5,034,900 |
|
|
|
4,967,624 |
|
Less: Accumulated depreciation and amortization
|
|
|
|
4,109,794 |
|
|
|
3,838,402 |
|
|
|
|
$ |
925,106 |
|
|
$ |
1,129,222 |
|
|
|
|
|
|
|
|
|
|
|
Goodwill and other intangible assets, net
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
$ |
1,239,368 |
|
|
$ |
1,239,368 |
|
Other
|
1-15 years
|
|
|
46,000 |
|
|
|
46,000 |
|
|
|
|
|
1,285,368 |
|
|
|
1,285,368 |
|
Less: Accumulated amortization
|
|
|
|
165,296 |
|
|
|
165,296 |
|
|
|
|
$ |
1,120,072 |
|
|
$ |
1,120,072 |
|
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 – DEBT
Bank Debt
The Company’s indebtedness under secured commercial loan agreements consisted of the following:
|
|
|
March 31, 2011
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
June 30, 2010
|
|
|
Bank term notes
|
|
$ |
– |
|
|
$ |
1,500,000 |
|
|
Bank line of credit
|
|
|
– |
|
|
|
840,863 |
|
|
Long-term debt
|
|
$ |
– |
|
|
$ |
2,340,863 |
|
|
Total bank debt
|
|
$ |
– |
|
|
$ |
2,340,863 |
|
On November 8, 2010, as a result of the sale of the Company’s toner business as more fully disclosed in Note 9, the Company terminated and repaid all of its outstanding balance under its existing revolving credit facility with Sovereign Bank. This facility was previously amended on September 27, 2010 so as to terminate on October 1, 2011. As amended, the advance limit under the line of credit was the lesser of: (a) $4,000,000; or (b) up to 80% of eligible domestic accounts receivable and up to the lesser of $1,000,000 or 75% of eligible foreign receivables plus up to the lesser of: (i) $2,500,000; or (ii) 50% of eligible inventory; or (iii) 60% of the maximum amount available to be advanced under the line. The line of credit was collateralized by a first priority security interest in substantially all of our U.S. based assets and our foreign receivables and required payments of interest only. As amended, the interest rate on the term note and the line of credit varied based on the bank’s prime rate and was equal to the greater of the bank’s prime rate plus 4% or 8%.
The revolving loan could have been converted into one or more term notes upon mutual agreement of the parties. Prior to its repayment with the bank, the Company had a $1,500,000 term note and an outstanding balance of $890,284 drawn under its revolving credit line.
The Company’s credit facility was subject to financial covenants. These covenants included monitoring a ratio of debt to tangible net worth and an ebitda or fixed charge coverage ratio, as defined in the loan agreements. At June 30, 2010, the Company was not in compliance with its Fixed Charge Coverage Ratio covenant, which was waived by the Company’s bank via the amendment dated September 27, 2010.
Convertible Debt
On September 24, 2008, the Company completed a $1,250,000 convertible debt financing with MicroCapital Fund, LP and MicroCapital Fund, Ltd. (“MicroCapital”). The Company issued three year notes, bearing interest at 10% payable quarterly and convertible into shares of the Company’s common stock at $1.65 per share. The Company also issued (a) five year warrants to purchase 378,787 shares of the Company’s common stock at $1.65 per share, and (b) three year warrants allowing MicroCapital to repeat its investment up to $1,250,000 on substantially the same terms and conditions.
The various elements of the September 24, 2008 transaction were recorded on a relative fair value basis in accordance with authoritative guidance. The $486,615 fair value of the warrants and the debt’s beneficial conversion feature was recorded to equity and as a debt discount to the value of the convertible note. This discount is being amortized using the effective interest method over the three year term of the convertible note. Amortization of debt discount on this convertible note payable amounted to $50,800 and $141,853, respectively, for the three and nine months ended March 31, 2011 and $37,856 and $105,708, respectively, for the three and nine months ended March 31, 2010. The remaining unamortized discount was $113,524 at March 31, 2011. In connection with this transaction, the Company also recognized a $63,955 increase in its deferred tax liabilities reflecting the non-deductible nature of future debt discount amortization that will result from the value of the beneficial conversion feature.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 - DEBT (CONTINUED)
On March 30, 2010, the Company entered into agreements with MicroCapital, whereby certain terms and conditions of the 10% convertible notes issued on September 24, 2008, were modified and all of the warrants issued and contingently issuable to MicroCapital were repurchased and cancelled. Modifications to the terms and conditions of the 10% convertible notes included elimination of convertibility of the notes and anti-dilution provisions. At March 31, 2010, as a result of this transaction, the MicroCapital debt is now reflected as 10% subordinated unsecured debt. Before the transaction, 2,272,726 shares of the Company’s common stock were issuable or contingently issuable. In consideration of the modifications of the loans and the repurchases of the warrants, 400,000 shares of the Company’s common stock were issued. In April 2010, the Company filed a registration statement, declared effective in May 2010, covering the resale of the shares of common stock issued in this transaction.
NOTE 5 – INCOME (LOSS) PER SHARE
Basic income (loss) per share is computed using the weighted average number of common shares outstanding. Diluted income (loss) per share is computed using the weighted average number of common shares outstanding as adjusted for the incremental shares attributable to outstanding options, restricted stock units and warrants to purchase common stock.
The following table sets forth the computation of the basic and diluted loss per share:
|
|
Three Months Ended
March 31,
|
|
|
Nine Months Ended
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
Numerator for basic and diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$ |
24,564 |
|
|
$ |
(3,506,394 |
) |
|
$ |
(1,513,449 |
) |
|
$ |
(5,718,098 |
) |
Income (loss) from discontinued operations
|
|
$ |
(7,584 |
) |
|
$ |
803,383 |
|
|
$ |
3,036,321 |
|
|
$ |
2,705,002 |
|
Net income (loss)
|
|
$ |
16,980 |
|
|
$ |
(2,703,011 |
) |
|
$ |
1,522,872 |
|
|
$ |
(3,013,096 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator :
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For basic loss per common share –
weighted average shares outstanding
|
|
|
13,354,088 |
|
|
|
12,291,692 |
|
|
|
12,845,972 |
|
|
|
12,025,210 |
|
Effect of dilutive securities - stock options,
unvested restricted stock units and warrants
|
|
|
72,437 |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
For diluted loss per common share –
weighted average shares outstanding adjusted
for assumed exercises
|
|
|
13,426,525 |
|
|
|
12,291,692 |
|
|
|
12,845,972 |
|
|
|
12,025,210 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$ |
(0.00 |
) |
|
$ |
(0.29 |
) |
|
$ |
( 0.12 |
) |
|
$ |
(0.48 |
) |
Income from discontinued operations
|
|
$ |
0.00 |
|
|
$ |
0.07 |
|
|
$ |
0.24 |
|
|
$ |
0.23 |
|
Net income (loss)
|
|
$ |
0.00 |
|
|
$ |
(0.22 |
) |
|
$ |
0.12 |
|
|
$ |
(0.25 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$ |
(0.00 |
) |
|
$ |
( 0.29 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.48 |
) |
Income from discontinued operations
|
|
$ |
0.00 |
|
|
$ |
0.07 |
|
|
$ |
0.24 |
|
|
$ |
0.23 |
|
Net income (loss)
|
|
$ |
0.00 |
|
|
$ |
(0.22 |
) |
|
$ |
0.12 |
|
|
$ |
(0.25 |
) |
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 5 – INCOME (LOSS) PER SHARE (CONTINUED)
The following options and warrants to purchase common stock were excluded from the computation of diluted loss per share for the three and nine months ended March 31, 2011 and 2010 because their exercise price was greater than the average market price of the common stock or as a result of the Company’s net loss from continuing operations for those periods:
|
|
Three Months Ended
March 31,
|
|
|
Nine Months Ended
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
Options and warrants
|
|
|
1,097,796 |
|
|
|
752,043 |
|
|
|
1,097,796 |
|
|
|
752,043 |
|
NOTE 6 – STOCK-BASED COMPENSATION
The effect of recording stock-based compensation for the three and nine months ended March 31, 2011 and 2010 was as follows:
|
|
Three Months Ended
March 31,
|
|
|
Nine Months Ended
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
Stock-based compensation expense by type of award:
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee stock options
|
|
$ |
3,369 |
|
|
$ |
69,034 |
|
|
$ |
138,139 |
|
|
$ |
209,589 |
|
Employee restricted stock units
|
|
|
6,926 |
|
|
|
44,243 |
|
|
|
129,031 |
|
|
|
185,596 |
|
Non-employee director restricted stock
units
|
|
|
– |
|
|
|
15,708 |
|
|
|
87,250 |
|
|
|
83,862 |
|
Amounts capitalized as inventory
|
|
|
– |
|
|
|
(3,237 |
) |
|
|
(1,407 |
) |
|
|
(8,368 |
) |
Total stock-based compensation expense
|
|
$ |
10,295 |
|
|
$ |
125,748 |
|
|
|
353,013 |
|
|
|
470,679 |
|
Tax effect of stock-based compensation recognized
|
|
|
2,517 |
|
|
|
– |
|
|
|
(114,603 |
) |
|
|
– |
|
Net effect on net income/ loss
|
|
$ |
7,778 |
|
|
$ |
125,748 |
|
|
$ |
238,410 |
|
|
$ |
470,679 |
|
As of March 31, 2011, the unrecorded deferred stock-based compensation balance was $28,548 after estimated forfeitures and will be recognized over an estimated weighted average amortization period of about 3 years.
During the three months ended March 31, 2011, the Company did not grant any stock options. During the nine months ended March 31, 2011, the Company granted 100,002 stock options with a grant date fair value of $12,780, after estimated forfeitures. During the three and nine months ended March 31, 2010, the Company did not grant any stock options. During the three months ended March 31, 2011, the Company did not grant any shares of restricted stock. During the nine months ended March 31, 2011, the Company granted 200,000 shares of restricted stock with a grant date fair value of $34,772, after estimated forfeitures. During the three and nine months ended March 31, 2010, the Company granted 577,000 shares of restricted stock with a grant date fair value of $243,050, after estimated forfeitures.
Valuation Assumptions
The Company estimates the fair value of stock options using a Black-Scholes option-pricing model. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model and the straight-line attribution approach with the following weighted-average assumptions:
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 – STOCK-BASED COMPENSATION (CONTINUED)
|
|
Three Months Ended
March 31,
|
|
|
Nine Months Ended
March 31,
|
|
|
|
2011 (b)
|
|
|
2010 (a)
|
|
|
2011
|
|
|
2010(a)
|
|
Risk-free interest rate
|
|
|
– |
|
|
|
– |
|
|
|
1.7 |
% |
|
|
– |
|
Dividend yield
|
|
|
– |
|
|
|
– |
|
|
|
0.0 |
% |
|
|
– |
|
Expected stock price volatility
|
|
|
– |
|
|
|
– |
|
|
|
64 |
% |
|
|
– |
|
Average expected life of options
|
|
|
– |
|
|
|
– |
|
|
4.8 years
|
|
|
|
– |
|
(a) No stock options were granted during the three or nine months ended March 31, 2010.
(b) No stock options were granted during the three months ended March 31, 2011.
Authoritative guidance issued by the FASB requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. For the current fiscal year, the expected stock price volatility assumption was determined using the Company’s historic volatility.
The Company uses the simplified method suggested by the SEC in authoritative guidance for determining the expected life of the options. Under this method, the Company calculates the expected term of an option grant by averaging its vesting and contractual term. Based on studies of the Company’s historic actual option terms, compared with expected terms predicted by the simplified method, the Company has concluded that the simplified method yields materially accurate expected term estimates. The Company estimates its applicable risk-free rate based upon the yield of U.S. Treasury securities having maturities similar to the estimated term of an option grant, adjusted to reflect its continuously compounded “zero-coupon” equivalent.
Equity Incentive Program
The Company’s equity incentive program is a broad-based, long-term retention program that is intended to attract and retain qualified management and technical employees, and align stockholder and employee interests. The equity incentive program presently consists of three plans (the “Plans”): the Company’s 1998 Incentive Plan, as Amended and Restated (the “1998 Plan”); the Company’s 2006 Stock Incentive Plan, as Amended and Restated (the “2006 Plan”); and the Company’s 2009 Stock Incentive Plan (the “2009 Plan”). Under these Plans, non-employee directors, officers, key employees, consultants and all other employees may be granted options to purchase shares of the Company’s stock, restricted stock units and other types of equity awards. Under the equity incentive program, stock options generally have a vesting period of three to five years, are exercisable for a period not to exceed ten years from the date of issuance and are not granted at prices less than the fair market value of the Company’s common stock at the grant date. Restricted stock units may be granted with varying service-based vesting requirements.
As of March 31, 2011, there are no common shares remaining available for future issuance under the 1998 Plan, which expired on June 17, 2008. Under the Company’s 2006 Plan, 1,000,000 common shares are authorized for issuance through awards of options or other equity instruments. As of March 31, 2011, 27,391 common shares were available for future issuance under the 2006 Plan. Under the Company’s 2009 Plan, 1,250,000 common shares are authorized for issuance through awards of options or other equity instruments. As of March 31, 2011, 187,998 common shares were available for future issuance under the 2009 Plan.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 – STOCK-BASED COMPENSATION (CONTINUED)
The following table summarizes the combined stock option plan and non-plan activity for the indicated periods:
|
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise Price
|
|
|
Balance outstanding at June 30, 2010
|
|
|
1,077,128 |
|
|
$ |
3.25 |
|
|
Nine months ended March 31, 2011:
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
100,002 |
|
|
|
0.34 |
|
|
Options exercised
|
|
|
– |
|
|
|
– |
|
|
Options cancelled/expired/forfeited
|
|
|
(79,334 |
) |
|
|
2.98 |
|
|
Balance outstanding at March 31, 2011
|
|
|
1,097,796 |
|
|
$ |
3.01 |
|
The options outstanding and exercisable at March 31, 2011 were in the following exercise price ranges:
|
|
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
|
Range of
Exercise
Prices
|
|
|
Number
Outstanding
|
|
|
Weighted
Average
Remaining
Contractual
Life-Years
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Number
Vested and
Exercisable
|
|
|
Weighted
Average
Exercise
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.34 to $0.85 |
|
|
|
166,002 |
|
|
|
5.7 |
|
|
$ |
0.39 |
|
|
|
166,002 |
|
|
$ |
0.39 |
|
|
$ |
1.00 to $2.00 |
|
|
|
395,115 |
|
|
|
2.3 |
|
|
|
1.97 |
|
|
|
395,115 |
|
|
|
1.97 |
|
|
$ |
2.01 to $6.33 |
|
|
|
536,679 |
|
|
|
3.7 |
|
|
|
4.58 |
|
|
|
536,679 |
|
|
|
4.58 |
|
|
|
|
|
|
|
1,097,796 |
|
|
|
3.5 |
|
|
$ |
3.01 |
|
|
|
1,097,796 |
|
|
$ |
3.01 |
|
At March 31, 2011, none of the Company’s exercisable options were in-the-money. Accordingly, all outstanding and exercisable options at that date had no aggregate intrinsic value. No options were exercised during the three or nine months ended March 31, 2011.
No stock options were granted during the three months ended March 31, 2011. The weighted average grant date fair value of options granted during the nine months ended March 31, 2011 was $0.21. No stock options were granted during the three or nine months ended March 31, 2010.
The Company settles employee stock option exercises with newly issued common shares.
Restricted Stock Units
No restricted stock units were granted during the three months ended March 31, 2011. The value of the restricted stock units is based on the closing market price of the Company’s common stock on the date of award. Stock-based compensation expense, net of estimate forfeitures, for restricted stock units for the three and nine months ended March 31, 2011 was $6,926 and $216,281, respectively.
As of March 31, 2011, there was $27,893 of total unrecognized deferred stock-based compensation after estimated forfeitures related to non-vested restricted stock units granted under the Plans. That cost is expected to be recognized over an estimated weighted average period of 3 years.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 – STOCK-BASED COMPENSATION (CONTINUED)
The following table summarizes the Company’s restricted stock unit activity for the indicated periods:
|
|
Number of
Shares
|
|
|
Grant Date
Fair Value
|
|
|
Weighted
Average Grant
Date Fair Value
Per Share
|
|
Balance unvested at June 30, 2010
|
|
|
592,460 |
|
|
$ |
456,330 |
|
|
$ |
0.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended March 31, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock units granted
|
|
|
200,000 |
|
|
|
50,025 |
|
|
|
0.25 |
|
Restricted stock units vested
|
|
|
(642,460 |
) |
|
|
(473,355 |
) |
|
|
0.74 |
|
Restricted stock units cancelled/forfeited
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
Balance unvested at March 31, 2011
|
|
|
150,000 |
|
|
$ |
33,000 |
|
|
$ |
0.22 |
|
NOTE 7 – ACCRUED PRODUCT WARRANTY COSTS
The Company provides a warranty for all of its consumable supply products. The Company’s warranty stipulates that it will pay reasonable and customary charges for the repair of a printer needing service as a result of using the Company’s products. The Company estimates the costs that may be incurred and records a liability in the amount of such costs at the time product revenue is recognized. Factors that may affect the warranty liability and expense include the number of units shipped to customers, historical and anticipated rates of warranty claims and cost per claim. The Company periodically assesses the adequacy of the recorded warranty liability and adjusts the amount as necessary. These expenses are classified as a separately captioned item in cost of goods sold.
Changes in accrued product warranty costs for the three and nine months ended March 31, 2011 and 2010 were as follows:
|
|
Three Months Ended
March 31,
|
|
|
Nine Months Ended
March 31
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
Accrued product warranty costs
at the beginning of the period
|
|
$ |
285,548 |
|
|
$ |
447,967 |
|
|
$ |
432,548 |
|
|
$ |
436,578 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warranties accrued during the period
|
|
|
37,578 |
|
|
|
468,261 |
|
|
|
447,529 |
|
|
|
1,456,124 |
|
Warranties settled during the period
|
|
|
(117,524 |
) |
|
|
(480,261 |
) |
|
|
(674,475 |
) |
|
|
(1,456,735 |
) |
Net change in accrued warranty costs
|
|
|
(79,946 |
) |
|
|
(12,000 |
) |
|
|
(226,946 |
) |
|
|
(611 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued product warranty costs
at the end of the period
|
|
$ |
205,602 |
|
|
$ |
435,967 |
|
|
$ |
205,602 |
|
|
$ |
435,967 |
|
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8 – LITIGATION AND CONTINGENCIES
The Company is involved in litigation from time to time in the ordinary course of its business. Based on information currently available to management, other than the action described below the Company does not believe that the outcome of any legal proceedings in which the Company is involved will have a material adverse impact on the Company.
On June 23, 2006, Xerox Corporation filed a patent infringement lawsuit in the United States District Court, for the Southern District of New York, Case No. 06CV4872, against Media Sciences International, Inc. and Media Sciences, Inc., alleging that the Company’s solid inks designed for use in the Xerox Phaser 8500 and 8550 printers infringe four Xerox-held patents related to the shape of the ink sticks in combination with the Xerox ink stick feed assembly. The suit sought unspecified damages and fees. In the Company’s answer and counterclaims in this action, it denied infringement and it sought a finding of invalidity of the Xerox patents in question. The Company also submitted counterclaims against Xerox for breach of contract and violation of U.S. antitrust laws, seeking treble damages and recovery of legal fees. On September 14, 2007, the court denied Xerox’s motion to dismiss the antitrust counterclaims brought by the Company. Pre-trial discovery on the infringement action was completed in September 2007. Pre-trial discovery on the Company’s antitrust action was completed in July 2008. In March 2009 the court dismissed, without prejudice, the Company’s antitrust claims relating to Xerox’s loyalty rebate programs. In the ruling, the court relied on a 2001 Settlement Agreement between the parties resulting from a different matter, and found that before such claims are pursued, the Company must submit to arbitration. In September 2009, the court dismissed the Company’s remaining antitrust claims not relating to Xerox’s loyalty rebate programs. In March 2010 the court issued a ruling on a Markman hearing held in November 2008. The Company believes the ruling to be highly favorable. In July 2010, the Company filed a motion for summary judgment in its favor based on the grounds that the ink sticks sold by the Company do not infringe the claims asserted by Xerox, as they were construed by the Court.
On April 22, 2011, Media Sciences International, Inc., Media Sciences, Inc. and Xerox Corporation entered into an agreement settling the patent infringement lawsuit, as more fully described in Note 11.
NOTE 9 – DISCONTINUED OPERATIONS
On November 8, 2010, the Company elected to discontinue selling toner related products and sold substantially all of its toner assets to Katun Corporation and one of its subsidiaries, including inventory, fixed assets and intangibles, as well as its business name and trademarks, for approximately $11 million cash. Of this purchase price approximately $1.1 million is to be held in escrow for a fifteen month period to cover indemnity claims as more fully described in the agreement. Katun Corporation has filed claims against the escrow which the Company is disputing and believes it will prevail. The Company subsequently entered into a licensing arrangement with Katun whereby it could continue to use the corporate name and other intellectual property. The Company recorded a net gain from this transaction of $2,869,440 (net of a tax provision of $244,560). The Company has reclassified all of its activity related to the toner business as discontinued operations for all periods presented prior to the sale.
In connection with this transaction the Company terminated 29 employees and accepted the resignations of the Company’s Chief Executive Officer and Chief Financial Officer. The Company incurred total severance expense in the amount of $1,682,427, $1,179,817 of which has been paid to date with the remaining $502,610 to be paid in May of 2011.
Upon the completion of the sale to Katun, the Company entered into a three year distribution agreement with Katun whereby Katun became the exclusive worldwide distributor of all of the Company’s solid ink products. This distribution agreement was terminated effective April 22, 2011. The Company will record an early termination penalty of $250,000 in the fourth quarter 2011.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 9 – DISCONTINUED OPERATIONS (CONTINUED)
Assets of discontinued operations are summarized as follows:
|
|
November 8, 2010
|
|
|
June 30, 2010
|
|
Inventories, net
|
|
$ |
4,501,160 |
|
|
$ |
4,055,235 |
|
Prepaid assets
|
|
|
130,748 |
|
|
|
39,419 |
|
Property and Equipment, net
|
|
|
832,300 |
|
|
|
722,908 |
|
Goodwill, net
|
|
|
2,464,159 |
|
|
|
2,464,159 |
|
Assets of discontinued operations
|
|
$ |
7,928,367 |
|
|
$ |
7,281,721 |
|
Summarized statement of operations data for discontinued operations are as follows:
|
|
Three months ended
March 31,
|
|
|
Nine months ended
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
Net sales
|
|
$ |
(254 |
) |
|
$ |
3,033,593 |
|
|
$ |
3,927,382 |
|
|
$ |
9,599,124 |
|
Pre-tax income (loss) from discontinued operations
|
|
$ |
(7,584 |
) |
|
$ |
803,383 |
|
|
$ |
328,526 |
|
|
$ |
2,705,002 |
|
Income tax expense (benefit)
|
|
|
– |
|
|
|
– |
|
|
|
161,645 |
|
|
|
– |
|
Gain on sale
|
|
|
– |
|
|
|
– |
|
|
$ |
3,114,133 |
|
|
|
– |
|
Income tax expense
|
|
|
– |
|
|
|
– |
|
|
|
244,693 |
|
|
|
– |
|
Income from discontinued operations, net of income taxes
|
|
$ |
(7,584 |
) |
|
$ |
803,383 |
|
|
$ |
3,036,321 |
|
|
$ |
2,705,002 |
|
NOTE 10 – CUSTOMER CONCENTRATIONS
During the three and nine months ended March 31, 2011, two customers represented 90% and 9% of the Company’s net revenues and two customers represented 16% and 13%,respectively of the Company’s net revenues. Among this group, the largest customer represents 91% of accounts receivable at March 31, 2011. During the three and nine months ended March 31, 2010, three customers represented 21%, 11%, and 11% of the Company’s net revenues and 20%, 11%, and 10%, respectively of the Company’s net revenues. This group represented 12%, 13% and 14% of the Company’s accounts receivable at March 31, 2010.
NOTE 11 – SUBSEQUENT EVENT
On April 22, 2011, Media Sciences International, Inc., Media Sciences, Inc. and Xerox Corporation entered into an agreement settling a patent infringement lawsuit before the United States District Court for the Southern District of New York, Case No. 06CV4872. Under the terms of the settlement, all claims of the parties in the litigation were resolved by the exchange of releases that the Company received from Xerox and that the Company provided to Xerox, and additional consideration exchanged between the parties. The settlement agreement was deemed entered into and became effective on April 22, 2011, and the parties agreed to apply for an order granting consent dismissal of the litigation. Under the terms of the settlement, the parties resolved, on mutually agreeable terms, infringement claims on certain Xerox-held patents related to the shape of the ink sticks, and the parties will exchange certain other business and financial considerations, over a brief ensuing period. The Company will continue to manufacture certain industrial ink products and to supply those products to Xerox for several months, after which the Company will cease manufacturing industrial ink products. The Company will deliver to Xerox certain inventory and assets related to industrial ink, the Company will assign certain patent and other intellectual property rights to Xerox, and the Company will cease manufacturing its inks for use in Xerox color printers. The Company will receive certain financial consideration as a result of the settlement to be recognized in the fourth quarter of 2011, along with any costs related to the settlement and wind down of the industrial ink operations. Each party will bear its own fees, costs and expenses relating to the litigation.
MEDIA SCIENCES INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11 – SUBSEQUENT EVENT (CONTINUED)
Subsequent to the Company completing the transaction with Katun Corporation, the Company’s Board of Directors has been reviewing various business, financial and operating options available to the Company. This review will now take into consideration that the Company is no longer actively engaged in the industrial ink business which is expected to be discontinued by the end of its current fiscal year. The Board is continuing such review and discussion.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
FORWARD LOOKING STATEMENTS
Our disclosure and analysis in this report contain forward-looking information, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, about our financial results and estimates, business prospects and products in development that involve substantial risks and uncertainties. You can identify these statements by the fact that they do not relate strictly to historic or current facts. These forward-looking statements use terms such as “believes,” “expects,” “may”, “will,” “should,” “anticipates,” “estimate,” “project,” “plan,” or “forecast” or other words of similar meaning relating to future operating or financial performance or by discussions of strategy that involve risks and uncertainties. From time to time, we also may make oral or written forward-looking statements in other materials we release to the public. These forward-looking statements are based on many assumptions and factors, and are subject to many conditions, including, but not limited to, our continuing ability to obtain additional financing, dependence on contracts with suppliers and major customers, competitive pricing for our products, demand for our products, changing technology, our introduction of new products, industry conditions, anticipated future revenues and results of operations, retention of key officers, management or employees, prospective business ventures or combinations and their potential effects on our business. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Forward-looking statements are made based upon management’s current expectations and beliefs concerning future developments and their potential effects upon our business.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. We cannot predict whether future developments affecting us will be those anticipated by management, and there are a number of factors that could adversely affect our future operating results or cause our actual results to differ materially from the estimates or expectations reflected in such forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in this section and those set forth in Item 6, “Factors Affecting Results Including Risks and Uncertainties” included in our Form 10-K for the year ended June 30, 2010, filed September 28, 2010. You should carefully review these risks and also review the risks described in other documents we file from time to time with the SEC. You are cautioned not to place undue reliance on these forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.
You should read the following discussion and analysis in conjunction with the information set forth in the unaudited financial statements and notes thereto, included elsewhere herein, and the audited financial statements and the notes thereto, included in our Form 10-K for the year ended June 30, 2010, filed September 28, 2010.
EXECUTIVE SUMMARY
After a second quarter of our fiscal year in which we sold our toner business to Katun Corporation and signed a master distribution agreement as well, Media Sciences experienced a stabilization of our sales and operations throughout the third quarter. Sales normalized after significant stocking orders occurred at the end of the second quarter to kick-off our new distribution agreement with Katun on solid inks, and operations settled after the changes made to both personnel and corporate structure occurred in December. However, we subsequently terminated the distribution agreement with Katun Corporation in connection with our settlement of a lawsuit with Xerox Corporation.
Our gross margins have been favorably affected by the decrease in product warranty expense and our ability to absorb our fixed costs over a larger revenue base. Reducing warranty expense has been, and remains, a high priority for the organization.
The Board of Directors and management undertook an effort during the quarter to further preserve and enhance shareholder value, by pursuing and successfully settling the litigation with Xerox. This was achieved subsequent to the quarter end (as is more fully disclosed in Note 11). The Board of Directors is continuing to review various business, financial and operating options available to the Company, and will advise at a later date.
RESULTS OF OPERATIONS
Net Revenues. For the three months ended March 31, 2011, as compared to the same period last year, net revenues increased by $87,000 or 4% from $2,141,000 to $2,228,000. This increase is primarily a result of the non-returnable orders received from the Company’s exclusive distributor of its solid ink products.
For the nine months ended March 31, 2011, as compared to the same period last year, net revenues increased by $403,000 or 6% from $6,669,000 to $7,072,000. This increase is primarily a result of the size of the orders from our new distributor. The effect of foreign currency changes for the nine months was a reduction in revenues of $127,000. We ended the quarter with an order backlog of $84,000. For the comparative year ago period, we had $434,000 of order backlog at March 31, 2010. The lower backlog at the end of the quarter is a result of the settlement agreement disclosed in Note 11.
Gross Profit. Consolidated gross profit for the three months ended March 31, 2011, compared to the same period last year, increased by $469,000 or 70% to $1,135,000 from $666,000. For the three months ended March 31, 2011, our gross margins increased to 51.0% from 31.1% in the comparative year ago period. The year-over-year increase in our gross profit and margins for the quarter was primarily attributed to absorption of our fixed costs due to an increase in sales and the decrease in product warranty expense.
Consolidated gross profit for the nine months ended March 31, 2011, compared to the same period last year, increased by $744,000 or 29% to $3,297,000 from $2,553,000. For the nine months ended March 31, 2011, our gross margins increased to 46.6% from 38.3% in the comparative year ago period. The year-over-year increase in our gross profit and margins for the nine months was similar to the reasons for our increase during the three months ended March 31, 2011.
Our margins reflect two main products. Generally, our non-industrial solid ink products generate greater margins than do our industrial inks. As a result, our margins can vary as a function of the industrial to non-industrial solid ink sales mix. We expect to see changes in our margins, dependent upon changes in our sales mix.
Research and Development. Research and development spending for the three months ended March 31, 2011, compared to the same period last year, decreased by $199,000 or 75% to $66,000 from $265,000. For the nine months ended March 31, 2011, compared to the same period last year, research and development spending decreased by $419,000 or 56% to $336,000 from $755,000. This decrease was a result of a decrease in personnel costs during the period.
Selling, General and Administrative. Selling, general and administrative expense, exclusive of depreciation and amortization, for the three months ended March 31, 2011, compared to the same period last year, decreased by $983,000 or 51% to $938,000 from $1,921,000. For the nine months ended March 31, 2011, selling, general and administrative expense, exclusive of depreciation and amortization, as compared to the same period last year, decreased by $1,552,000 or 30% to $3,688,000 from $5,240,000.
The sale of the toner business resulted in a significant changes in the size, complexity and nature of operations of the Company. As a result, the Company changed its senior management team and many other functions were eliminated, accordingly, personnel and related costs were significantly reduced during the nine month period ended March 31, 2011. The Company did record a severance expense of approximately $1.7 million related to the organizational changes.
Depreciation and Amortization. Non-manufacturing depreciation and amortization expense for the three months ended March 31, 2011 compared to the same period last year, decreased by $16,000 or 37% to $29,000 from $45,000. For the nine months ended March 31, 2011, compared to the same period in 2010, non-manufacturing depreciation and amortization expense decreased by $77,000 or 42% to $106,000 from $183,000. The decrease in non-manufacturing depreciation and amortization expense reflects the decline in our non-manufacturing fixed asset additions over the comparative periods.
Interest Expense. For the three and nine months ended March 31, 2011, we incurred interest expense of $31,000 and $166,000, respectively. This compares with interest expense of $89,000 and $266,000, respectively, for the prior year’s three and nine months ended March 31, 2010. These changes were the result of year-over-year decreases in the Company’s level of debt, including the repayment of the Company’s bank revolving credit facility, offset by higher interest rates.
Income Taxes. For the three months ended March 31, 2011, we recorded income tax expense of $4,000. This compares with income tax expense of $2,033,000, for the three months ended March 31, 2010. For the nine months ended March 31, 2011, we recorded income tax benefits of $1,299,000. This compares with income tax expense of $1,935,000, for the nine months ended March 31, 2010. As a result of the sale of the toner business and the related goodwill, the Company no longer needed to provide for the exposure related to its indefinitely lived intangibles and adjusted its deferred taxes accordingly. Additionally, as a result of the gain on the sale of the toner business, the Company reduced certain of its valuation allowances resulting in a tax benefit from continuing operations and an offsetting tax provision recorded against the gain on discontinued operations.
Discontinued Operations. Discontinued operations are related to toner products that were sold to Katun Corporation. We had a loss from discontinued operations of $8,000 for the three month period ended March 31, 2011 and income from discontinued operations of $167,000 for the nine month period ended March 31, 2011. For the comparable year ago period, we had income of $803,000 and $2,705,000 for the three and nine month period ended March 31, 2010, respectively. We recorded a gain on the sale of the toner assets, net of taxes, of $2,869,000 during the nine months ended March 31, 2011. Certain amounts reflected in the accompanying Unaudited Condensed Consolidated Financial Statements for the three and nine months ended March 31, 2011 and 2010, have been adjusted to classify the results as discontinued operations.
Net Income. For the three and nine months ended March 31, 2011, we earned $17,000 ($0.00 per share basic and diluted) and $1,523,000 ($0.12 per share basic and diluted), respectively. This compares with a net loss of $2,703,000 ($0.22 per share basic and diluted) and $3,013,000 ($0.25 per share basic and diluted), respectively, for the three and nine months ended March 31, 2010. The difference results from the items previously mentioned above as well as the gain, net of taxes, of approximately $2.87 million from the sale of the toner business.
RECENT ACCOUNTING PRONOUNCEMENTS
See Note 2 to the condensed consolidated financial statements, included in Item 1 of Part I of this report, for a full description of recent accounting pronouncements, including the expected dates of adoption and estimated effects on our consolidated financial statements, which is incorporated herein by reference.
CRITICAL ACCOUNTING POLICIES
For a description of our critical accounting policies see Management’s Discussion and Analysis of Financial Condition and Results of Operations and Note 1 to the audited financial statements included in our Form 10-K for the year ended June 30, 2010 filed September 28, 2010. There were no significant changes in our critical accounting policies during the three months ended March 31, 2011.
LIQUIDITY AND CAPITAL RESOURCES
During the nine months ended March 31, 2011, our cash and equivalents increased by $6,311,000 to $6,628,000. Operating activities used $1,052,000 while investing activities provided $9,705,000 and financing activities utilized $2,341,000. Net cash provided in investing activities of $9,705,000 included the proceeds from the sale of plant equipment and tooling, and purchases of property and equipment. Purchases of property and equipment represented an increase of $237,000 or 60% over the $148,000 invested during the comparative nine months year ended March 31, 2010. Proceeds from the sale of the toner business were $11,042,500, including restricted cash.
We utilized $1,052,000 of cash in our operating activities for the nine months ended March 31, 2011 as compared to utilizing $616,000 during the comparative nine months ended March 31, 2010. The $1,052,000 of cash used by operating activities during the nine months ended March 31, 2011 resulted from a $1,523,000 income from operations, non-cash charges totaling $317,000, a gain from the sale of operating toner assets of $2,869,000, and $611,000 of cash provided as a result of an increase in our non-cash working capital (current assets less cash and cash equivalents net of current liabilities). The most significant drivers behind the $611,000 increase in our non-cash working capital include: (1) a $749,000 decrease in our trade obligations and other accrued expenses; (2) a $1,310,000 decrease in our accounts receivable; (3) a $227,000 decrease in accrued product warranties; and (4) a decrease in our inventories of $179,000.
As a result of the sale of the toner business the Company terminated its then existing credit facility with Sovereign Bank. Although the Company believes it currently has sufficient working capital to maintain and grow its business, it may, at a future time, determine that it will need to obtain another credit facility from a financial institution or other funding source. There can be no guaranty that the Company will be able to obtain that facility and such failure may adversely impact the Company.
SEASONALITY
Historically we have experienced some seasonality in our business, especially during the summer months and other periods such as calendar year end.
MARKET RISK
We are exposed to various market risks, including changes in foreign currency exchange rates and commodity price inflation. Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange, commodity price inflation and interest rates. We do not hedge our foreign currency exposures and we had no forward foreign exchange contracts outstanding as of March 31, 2011. In the future we may hedge these exposures based on our assessment of their significance.
Foreign Currency Exchange Risk
The effect of foreign currency changes for the nine months was a reduction in revenues of $127,000.
Commodity Price Inflation Risk
Over the last twelve months, we have experienced increases in raw material costs and the costs of shipping and freight to deliver those materials and finished products to our facility and, where paid for by us, shipments to customers. While we have historically offset a significant portion of this inflation in operating costs through increased productivity and improved yield, recent increases have impacted profit margins. We are pursuing efforts to improve our procurement of raw materials. We can provide no assurance that our efforts to mitigate increases in raw materials and shipping and freight costs will be successful.
Interest Rate Risk
At March 31, 2011, we did not have debt outstanding under any lines of credit or term notes.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Reference is made to the information set forth under the caption “Market Risk” included in Item 2 of Part I of this report, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Also refer to the last paragraph of “Liquidity and Capital Resources” contained in Item 2 of Part I this report for additional discussion of issues regarding liquidity.
Evaluation of Disclosure Controls and Procedures. As required by Rule 13a-15(b) under the Exchange Act, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting. There has been no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act, that occurred during the quarter ended March 31, 2011, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
The information set forth above under Note 8 contained in the “Notes to condensed consolidated financial statements” in Item 1 of Part I of this report is incorporated herein by reference.
A description of factors that could materially affect our business, financial condition or operating results is included in Item 1A “Risk Factors” of our Form 10-K for the year ended June 30, 2010, filed September 28, 2010 and is incorporated herein by reference.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Not applicable.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable.
Not applicable.
Not applicable.
The following exhibits are filed with this report:
Exhibit No.
|
|
Description
|
31.1*
|
|
Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a)
|
31.2*
|
|
Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a)
|
32.1*
|
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350
|
32.2*
|
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350
|
* Filed herewith
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
MEDIA SCIENCES INTERNATIONAL, INC.
|
|
|
|
Dated: May 13, 2011
|
By:
|
/s/ Marc D. Durand
|
|
|
|
Marc D, Durand
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
Dated: May 13, 2011
|
By:
|
/s/ Denise Hawkins
|
|
|
|
Denise Hawkins
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|